ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,427.13
-2.31%
US Tech 100
18,615.20
-3.17%
Dow Jones
39,853.87
-1.25%
Brent Oil
80.735
-0.05%
Bitcoin
65,279.37
-0.98%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSXV

  6. Cannara Biotech Inc (LOVE) Quote

Cannara Biotech Inc

Cannara Biotech Inc (LOVE)

Cannara Biotech Inc
Lovesac Company
0.56
-0.04
(-6.67%)
Closed July 24 4:00PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.56
Bid
0.54
Ask
0.56
Volume
43,075
0.54 Day's Range 0.60
0.52 52 Week Range 1.14
Market Cap
50.571M
Previous Close
0.60
Open
0.60
Last Trade
1000
@
0.56
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
28,081
Shares Outstanding
90,305,000
Dividend Yield
-
PE Ratio
7.28
Earnings Per Share (EPS)
0.08
Revenue
57.56M
Net Profit
6.95M

About Cannara Biotech Inc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.cannara.ca
Headquarters
Saint-laurent, Quebec, Can
Founded
1970
Cannara Biotech Inc is listed in the Pharmaceutical Preparations sector of the TSX Venture Exchange with ticker LOVE. The last closing price for Cannara Biotech was $0.60. Over the last year, Cannara Biotech shares have traded in a share price range of $ 0.52 to $ 1.14.

Cannara Biotech currently has 90,305,000 shares outstanding. The market capitalization of Cannara Biotech is $54.18 million. Cannara Biotech has a price to earnings ratio (PE ratio) of 7.28.

LOVE Latest News

More News

Cannara Biotech Reports Q3 2024 Financial Results

Gross cannabis revenues before excise taxes increased to $26.2 million in Q3 2024 from $20.6 million in Q3 2023, a $5.6 million or 27.6%, increase. Total revenues, net of excise taxes, increased...

July 23 2024
GlobeNewswire Inc.

Cannara Biotech publie ses résultats financiers pour le deuxième trimestre de 2024

Cannara Biotech publie ses résultats financiers pour le deuxième trimestre de 2024 Canada NewsWire MONTRÉAL, le 29 avril 2024 Les revenus nets ont augmenté pour atteindre 19,7...

April 29 2024
PR Newswire (Canada)

Cannara Biotech Announces Record-Breaking Q1 2024 Results: Continued Robust Growth and Market Expansion

Cannara Biotech Announces Record-Breaking Q1 2024 Results: Continued Robust Growth and Market Expansion Canada NewsWire MONTREAL, Jan. 30, 2024 Record Q1 net revenues of $19.5 million...

January 30 2024
PR Newswire (Canada)

Cannara Biotech Announces Engagement of Market Maker Services from Independent Trading Group ("ITG")

Cannara Biotech Announces Engagement of Market Maker Services from Independent Trading Group ("ITG") Canada NewsWire MONTREAL, Jan. 8, 2024 MONTREAL, Jan. 8, 2024 /CNW/ - Cannara...

January 08 2024
PR Newswire (Canada)

Cannara Biotech annonce la tenue virtuelle de son assemblée générale annuelle des actionnaires le 25 janvier 2024

Cannara Biotech annonce la tenue virtuelle de son assemblée générale annuelle des actionnaires le 25 janvier 2024 Canada NewsWire MONTRÉAL, le 13 déc. 2023 MONTRÉAL, le...

December 13 2023
PR Newswire (Canada)

Cannara Biotech tiendra une webdiffusion à l'intention des investisseurs le jeudi 14 décembre 2023

Cannara Biotech tiendra une webdiffusion à l'intention des investisseurs le jeudi 14 décembre 2023 Canada NewsWire MONTRÉAL, le 11 déc. 2023 MONTRÉAL, le 11 déc. 2023...

December 11 2023
PR Newswire (Canada)

Cannara Biotech Inc. publie les résultats du quatrième trimestre et de l'exercice financier 2023 Poursuite de la croissance et de la rentabilité records

Cannara Biotech Inc. publie les résultats du quatrième trimestre et de l'exercice financier 2023 Poursuite de la croissance et de la rentabilité records Canada...

December 07 2023
PR Newswire (Canada)

Cannara Biotech Inc. Reports Record Q3 2023 Financial Results with Net Revenues of $15.9 Million and Net Income of $2.9 million

Cannara Biotech Inc. Reports Record Q3 2023 Financial Results with Net Revenues of $15.9 Million and Net Income of $2.9 million Canada NewsWire MONTREAL, July 27, 2023 Three- and nine-month net...

July 27 2023
PR Newswire (Canada)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.07-11.11111111110.630.670.54606300.61308525CS
4-0.12-17.64705882350.680.710.52392570.62970104CS
12-0.24-300.80.840.52280810.69764869CS
26-0.35-38.46153846150.911.040.52263170.80011647CS
52-0.36-39.13043478260.921.140.52206970.849621CS
1560.39229.4117647060.171.150.085973970.19586059CS
2600.42500.161.150.0851418800.18137255CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PBMPsyence Biomedical Ltd
$ 0.998
(154.98%)
25.64M
ASNSActelis Networks Inc
$ 1.7899
(29.70%)
3.44M
VKTXViking Therapeutics Inc
$ 60.49
(20.00%)
1.47M
PROPPrairie Operating Company
$ 10.61
(15.20%)
498
ATXIAvenue Therapeutics Inc
$ 4.0297
(13.19%)
115.03k
OSTOstin Technology Group Company Ltd
$ 0.37
(-15.91%)
702.16k
MXLMaxLinear Inc
$ 18.75
(-15.88%)
312.08k
NUZENuZee Inc
$ 2.839
(-15.25%)
2.08M
DUOFangDD Network Group Ltd
$ 0.4602
(-14.46%)
212.62k
WRNTWarrantee Inc
$ 0.284
(-13.89%)
77.87k
PBMPsyence Biomedical Ltd
$ 0.998
(154.98%)
25.64M
SLNASelina Hospitality PLC
$ 0.0434
(-5.03%)
15.1M
NVDANVIDIA Corporation
$ 115.20
(0.83%)
11.78M
SQQQProShares UltraPro Short QQQ
$ 8.95
(-1.21%)
5.43M
ASNSActelis Networks Inc
$ 1.7899
(29.70%)
3.44M

Discussion

View Full Feed
zab zab 1 minute ago
There easy to look for, just type in presidential polls. It's fine, stay in denial, then in November you can claim the election was stolen.
Disquisition Disquisition 2 minutes ago
It is not 100% accurate. You have left many other considerations out.

Well, Joseph Robinette Biden, Jr. only listed two criteria for his selection process - race and gender - so that is all I'm referencing as well.

Sounds like your gripe is, in fact, with him. Not with
Milesblue42 Milesblue42 2 minutes ago
Is this a Securities Violation?? Insider Info??

I don't know if I should share this at the risk that Julian moulton might get upset with me. but he just replied to my post a few minutes ago 4:23 pm I sent him Monday. quote. we are working on a huge opportunity I cannot share many deta
RONN
fuagf fuagf 3 minutes ago
Every good common sense person could only end where you have ended. Onward the common sense goodwill good guys!
3Angels120702 3Angels120702 3 minutes ago
News soon I'm thinking
MWWC
mick mick 3 minutes ago
Golfbet Insider Rob Bolton | TOTT Podcast | 3M Open


https://youtu.be/vyMx1-uQOJw

https://www.youtube.com/watch?v=vyMx1-uQOJw&t=42s&ab_channel=Golfbet
jpike jpike 3 minutes ago
I always buy on pullbacks but I missed loading more today. No problem, still loaded with shares.
PAYS
Kool Aid Man Kool Aid Man 4 minutes ago
Park said "I will also be converting my $100,000 personal loan to common stock at $.02 per share to eliminate such JP3E debt.”

Where's the proof that he personally loaned SPZI $100K?

$100k divided by .02= 5 million shares. There are only 89,497 left in the A/S to issu
SPZI
w6w9t8015 w6w9t8015 4 minutes ago
Spin off is OTC Q's required answer. Spin off means the EXISTING OPS in $HIRU ie: Liberia mining, H20 packing business, H20 eqipment etc. Company answered that in Q2 filing. Hope this link assists https://investopedia.com/terms/s/spinoff.asp

Other OTC co want H20 stuff to pay with
HIRU
WebSlinger WebSlinger 5 minutes ago
8 cents by Friday?????
KBLB
fuagf fuagf 5 minutes ago
100% Whatever the reason the result is a good one for the good guys. :-)
And there is no question at all as to who are the good guys.
Asahi2017 Asahi2017 6 minutes ago
$$$$
SEQP
ALDRADJKD123 ALDRADJKD123 6 minutes ago
Doubt Trump ever did hide……LMFAOOOOOO

You total idiots will try and spin any garbage…..
MetaMonster MetaMonster 6 minutes ago
AI Power FOXO
FOXO
mauismart mauismart 6 minutes ago
I think you pur in too much thought in this post. What kind of thought who knows
AVXL
tommyg61 tommyg61 6 minutes ago
It was excellent.
ZNOG
JakBqk JakBqk 7 minutes ago
Bid Price is 0003 because CEO strategy destroyed all but about 1 tick of stock value.
He does not care about bagholders.
The name change was already priced in as positive and then the gain was lost..
DRNK
webprods webprods 7 minutes ago
Lol
HIRU
ALDRADJKD123 ALDRADJKD123 7 minutes ago
And yet you show none much less dozens……🤣
slipihiv slipihiv 8 minutes ago
I want my at least 25% of my money back, BallAss lies got me in to this stock few years ago, one of my worst investment, I hope BallAss will end up in prison!
UBQU
1vman 1vman 8 minutes ago
*****🅰️🅰️ 🅰️Blackrock did increase their shares of GME period - its in the filings -- whoops BTW Any proof blackrock didn't lend out shares to GME ( Gameturd ) shorters ???


https://investorshub.advfn.com/ui
GME
Capt_Smith77 Capt_Smith77 9 minutes ago
Not really what I was asking about, but okay.

China is a much smaller part of their market at the moment, but I'm reading where revenues could surprise in that area as well.
NVDA

Your Recent History

TSXV
LOVE
Cannara Biotech
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved